Techdow heparin recall: 251,000 vials without sterility assurance
Shenzhen Techdow recalled one lot of heparin sodium injection 5,000 units/mL sold in the US by Hepalink USA. The reason given is lack of assurance of sterility.
Is your product on this list?
Products at risk. Who's in.
Recalledin the firm's recall notice
| MOLECULE | FORM | SOLD IN THE US BY | LINK TO SITE | RISK | WHO'S IN | Action |
|---|---|---|---|---|---|---|
| Heparin sodium | Injection 5,000 USP units/mL, 1 mL multi-dose vial | Hepalink USA | RECALLED | RECALLED | 37 API (33 US DMF) · 20 FDF | See who's in |
FDA often redacts product names in its letters. Rows marked "FDA label" come from openFDA drug labels that name this site. "Who's in" counts manufacturers of the same molecule in the API-FDF database; names and contacts are inside.
What FDA found
- One lot, CU03232A, expiring 31 January 2028.
- 251,000 vials of 1 mL, distributed nationwide by Hepalink USA.
- Reason given: lack of assurance of sterility. FDA classed it Class II.
- Recall started on 1 October 2026.
Timeline
How it got here
1 OCT 2026
Techdow starts the recall
28 OCT 2026
FDA posts it as Class II